Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Paclitaxel|BIOLOGICAL: trastuzumab|DRUG: Neratinib
Sponsor: NSABP Foundation Inc
Collaborators: Pfizer